An osteochondral lesion is damage that extends through the cartilage lining a joint and into the bone just beneath it. The injury involves what orthopedic specialists call the “osteochondral unit,” a layered structure made up of the smooth articular cartilage, a thin zone of calcified cartilage, and the underlying subchondral bone. Unlike a purely cartilage injury that stays at the surface, an osteochondral lesion disrupts that full composite, and because bone and cartilage heal by different rules, treatment gets complicated fast.
The Osteochondral Unit and Why It Matters
Every joint that moves freely, from your knee to your ankle to your elbow, relies on that layered sandwich of cartilage and bone working together. The articular cartilage is anchored to the subchondral bone through the calcified cartilage layer, and together these structures form a unit uniquely adapted to transferring and absorbing load.1PubMed. Changes in the osteochondral unit during osteoarthritis: structure, function and cartilage-bone crosstalk When you walk, jump, or pivot, the cartilage cushions the impact while the bone underneath distributes forces across a wider area. Damage to just one layer destabilizes the other. A crack in the subchondral bone can undermine the cartilage above it, and eroded cartilage can expose and overload the bone beneath. This mutual dependence is what makes osteochondral lesions more serious than cartilage-only wear.
Where Osteochondral Lesions Happen
The ankle and knee are the two joints most frequently affected. In the ankle, the lesion almost always sits on the dome of the talus, the rounded bone that fits into the ankle mortise. These talar lesions tend to appear in two characteristic spots: the posteromedial dome (toward the inner, back side) and the anterolateral dome (toward the outer, front side). Posteromedial lesions are often deeper and wider and sometimes appear without a clear history of injury, while anterolateral lesions are more commonly tied to a traumatic event and are associated with lateral ligament damage in roughly a third of cases.2PubMed. Osteochondral lesions of the talar dome
In the knee, osteochondral lesions usually involve the femoral condyles, the rounded knobs at the lower end of the thighbone. Osteochondral lesions can also develop in the elbow, hip, and shoulder, though those presentations are less common and less well studied.
Causes and Risk Factors
Acute trauma is the most straightforward culprit. An ankle sprain or a direct blow to a joint can crack or shear off a piece of cartilage along with the bone beneath it. Talar osteochondral lesions are frequently a consequence of such injuries, including the kind of awkward ankle roll that many people brush off as a “bad sprain.”3PubMed Central. Osteochondral lesions of talus But trauma alone does not explain every case. Some lesions appear without a single memorable injury, suggesting that repetitive low-grade stress can accumulate and quietly weaken the osteochondral unit over time.
The condition known as osteochondritis dissecans (OCD), which is essentially a specific subtype of osteochondral lesion, has been the subject of extensive debate about causation. Multiple theories have been proposed, including local blood supply disruption (ischemia), abnormal patterns of subchondral bone development, genetic factors, and repetitive mechanical microtrauma, with a likely interplay among them.4PubMed Central. Osteochondritis dissecans of the knee: Epidemiology, etiology, and natural history A systematic review of the pathogenesis literature concluded that subchondral bone ischemia and fracturing appear to be the key events that trigger the onset and progression of OCD.5PubMed Central. Osteochondritis Dissecans of the Knee: Etiology and Pathogenetic Mechanisms. A Systematic Review.
The Genetic Angle
There is growing evidence that some people are genetically predisposed. Genome-wide association studies in humans (and even in horses and pigs, which develop similar lesions) have identified genes that increase OCD risk, and those genes tend to cluster around functions related to cartilage and bone biology.6PubMed Central. Emerging genetic basis of osteochondritis dissecans In at least one family, researchers traced a dominant form of OCD to a specific mutation in the aggrecan gene (ACAN), which encodes a major structural protein in cartilage. The mutation disrupted the protein’s ability to bind to other molecules in the cartilage matrix, essentially weakening the tissue’s internal scaffolding.7The American Journal of Human Genetics. A Missense Mutation in the Aggrecan C-type Lectin Domain Disrupts Extracellular Matrix Interactions and Causes Dominant Familial Osteochondritis Dissecans That does not mean most osteochondral lesions are inherited, but it does suggest that some people’s cartilage may be structurally more vulnerable from the start.
Symptoms to Watch For
Osteochondral lesions are sneaky in that their symptoms overlap heavily with sprains, tendon problems, and general joint soreness. In the ankle, the typical complaints are pain, swelling, stiffness, and sometimes mechanical symptoms like catching or locking.8PubMed Central. Management of Osteochondral Lesions of the Talar Dome In the knee, the presentation is similar: aching pain that worsens with activity, occasional swelling, and that unsettling sensation that something is catching inside the joint when you bend it. Because these symptoms are nonspecific, many osteochondral lesions go undiagnosed for months or even years, especially when the initial injury seemed minor. If ankle pain lingers well beyond the expected recovery time for a sprain, an osteochondral lesion deserves a spot on the differential diagnosis.
How They Are Diagnosed
X-rays can sometimes reveal bony changes, but the real workhorse for detection is MRI. For talar lesions, MRI achieves sensitivity up to 96% and specificity between 96% and 100%, with strong correlation to what surgeons actually find during arthroscopy.9PubMed Central. The role of imaging in the diagnosis, staging, and management of the osteochondral lesions of the talus MRI is also highly sensitive (around 97%) for identifying unstable lesions, meaning fragments that are at risk of separating or have already detached, which is one of the most important pieces of information for planning treatment. A systematic review and meta-analysis of MRI’s ability to assess lesion stability across joints reported a pooled sensitivity of about 92% and specificity of about 85%.10PubMed. Clinical Value of MRI in Assessing the Stability of Osteochondritis Dissecans Lesions: A Systematic Review and Meta-Analysis
Multiple staging systems have been developed to classify osteochondral lesions based on imaging and arthroscopic findings. These systems create a common language for describing lesion severity, but their practical value has limits: they rarely guide treatment directly and do not account for lesion size, which is actually one of the more important factors in deciding what procedure to use.11British Journal of Radiology. The role of imaging in the diagnosis, staging, and management of the osteochondral lesions of the talus – Section: Staging For very thin cartilage areas like the talus, standard 1.5-Tesla MRI can struggle with spatial resolution. In those situations, cone-beam CT arthrography (a CT scan performed after injecting contrast into the joint) can provide more precise cartilage assessment.12PubMed Central. Staging of Osteochondral Lesions of the Talus: MRI and Cone Beam CT
When Non-Surgical Treatment Works (and When It Does Not)
For small, stable lesions, especially in younger patients, the first approach is usually conservative: rest, activity modification, bracing or casting, and gradual rehabilitation. In the knee, restricting strenuous activity appears to be the most supported non-surgical strategy, while immobilization and limiting weight-bearing have not shown clear benefit.13PubMed Central. Osteochondritis Dissecans of the Knee – Conservative Treatment Strategies: A Systematic Review
The honest picture for non-surgical management of talar osteochondral lesions is sobering. A systematic review found an overall pooled success rate of about 45%, and roughly 46% of patients who initially tried conservative care eventually converted to surgery.14PubMed Central. Non-operative management for osteochondral lesions of the talus: a systematic review of treatment modalities, clinical- and radiological outcomes Those are essentially coin-flip odds. Still, when non-surgical treatment does work, the long-term outlook can be reasonable. In one observational study with a 14-year average follow-up, about three-quarters of successfully treated talar lesions showed no progression of ankle arthritis.15PubMed Central. Long-term Prognosis After Successful Nonoperative Treatment of Osteochondral Lesions of the Talus: An Observational 14-Year Follow-up Study
Children and adolescents with open growth plates generally have a significantly better shot at healing without surgery. Outcomes for juvenile OCD are significantly better than for adult OCD, owing to the skeleton’s still-active growth and repair capacity.16PubMed. Surgical management of juvenile osteochondritis dissecans of the knee
Surgical Options When Conservative Care Falls Short
When a lesion is unstable, large, or has failed non-surgical treatment, surgery becomes the next step. The specific procedure depends heavily on lesion size, depth, location, and whether the patient is a competitive athlete or someone who just wants to walk comfortably.
Bone Marrow Stimulation (Microfracture)
Microfracture is the most common first-line surgical approach, particularly for smaller lesions. The surgeon uses a small awl to poke holes in the exposed bone, allowing blood and stem cells from the marrow to fill the defect and form a repair layer. The procedure is minimally invasive and cost-effective, but it comes with a well-known limitation: the repair tissue that forms is mainly fibrocartilage rather than the original hyaline cartilage, and fibrocartilage has inferior mechanical properties that tend to break down over time.17PubMed Central. Microfracture for cartilage repair in the knee: current concepts and limitations of systematic reviews For many patients, microfracture buys years of improved function, but it may not be the final answer for young, active people with large defects.
Osteochondral Autograft Transfer (OATS/OAT)
This approach involves harvesting one or more small cylindrical plugs of healthy cartilage and bone from a non-weight-bearing area of the patient’s own joint and pressing them into the defect. Because the transplant contains living cartilage with its natural hyaline structure already intact, it sidesteps the fibrocartilage problem of microfracture. Advantages include single-stage surgery, early ambulation, and predictable return to sport.18PubMed Central. Osteochondral Autograft Transfer for Focal Cartilage Lesions of the Knee With Donor-Site Back-Fill Using Precut Osteochondral Allograft Plugs and Micronized Extracellular Cartilage Augmentation The trade-off is that the donor site itself can become a source of pain, and the usable harvest area is limited, making this technique best suited for small-to-medium defects.
Matrix-Induced Autologous Chondrocyte Implantation (MACI)
MACI is a two-stage procedure. First, a small sample of the patient’s cartilage cells is harvested. Those cells are then expanded in a lab and seeded onto a collagen scaffold, which is later implanted into the defect and secured with fibrin glue.19Operative Techniques in Sports Medicine. Indications, Techniques, Outcomes for Matrix-Induced Autologous Chondrocyte Implantation (MACI) The technique is designed for cartilage defects with minimal bone involvement. A systematic review of outcomes at a minimum 10-year follow-up found durable improvements in patient-reported outcomes, satisfactory defect fill on MRI, and low rates of reoperation, supporting MACI as a long-term treatment for focal cartilage defects of the knee.20PubMed Central. Minimum 10-Year Outcomes of Matrix-Induced Autologous Chondrocyte Implantation in the Knee: A Systematic Review
Osteochondral Allograft Transplantation
For large defects (generally over 3 cm²), deep lesions involving significant subchondral bone damage, or cases where a prior procedure has failed, fresh osteochondral allografts from a tissue donor become the best remaining option.21PubMed Central. Osteochondral Allografts for Large Osteochondral Lesions of the Knee Joint: Indications, Surgical Techniques and Results Allograft transplantation delivers living cartilage and structured bone in sizes that autograft simply cannot match. Outcomes have shown reliable improvement in pain and daily function.22Arthroscopy Techniques. Technical Note Fresh Femoral Osteochondral Allograft Transplantation Using a Single-Plug Technique for Large Osteochondral Defects of the Knee The main challenge is logistics: fresh allografts have a limited shelf life and require coordination with a tissue bank.
Rehabilitation After Surgery
Recovery from osteochondral surgery used to be extremely cautious, with patients kept off their feet for weeks and range of motion tightly restricted. That approach protected the repair but did little to prepare the patient for real-world activity. More recent literature supports accelerated protocols across a range of procedures, including OATS, MACI, and allograft transplantation. These newer programs emphasize early but progressive weight-bearing, early range of motion, and then a structured escalation toward higher-level activity and sport.23PubMed Central. The Evolution of Rehabilitation and Return to Sport Following Cartilage Surgery
A randomized study comparing a 6-week versus an 8-week return to full weight-bearing after MACI found that the faster timeline produced comparable clinical and MRI-based outcomes beyond five years, without damaging the graft.24PubMed. An accelerated 6-week return to full weight bearing after matrix-induced autologous chondrocyte implantation results in good clinical outcomes to 5 years post-surgery For traumatic cartilage injuries of the knee in athletes, the majority of published protocols begin partial weight-bearing within the first two weeks after surgery, progressing to full weight-bearing over the following several weeks.25PubMed Central. Timing of postoperative weightbearing in the treatment of traumatic chondral injuries of the knee in athletes – A systematic review of current concepts in clinical practice Advances like blood flow restriction training have also expanded what is possible during the early recovery window.
Return to Sport After Talar Osteochondral Surgery
For active people, the bottom-line question is often: will I get back to what I was doing? A systematic review covering over 2,300 cases of surgically treated talar osteochondral defects paints a broadly encouraging picture. The pooled rate of return to sport at any level was about 88% after bone marrow stimulation, 90% after autograft transplantation, 87% after autologous chondrocyte implantation, and 97% after internal fixation (in a smaller group of patients). Getting back to the preinjury level of sport was harder: about 79% after bone marrow stimulation, 72% after autograft, and 69% after chondrocyte implantation. The typical time to return ranged from about 13 to 26 weeks, depending on the procedure.26PubMed Central. Return to Sports After Surgical Treatment of Osteochondral Defects of the Talus: A Systematic Review of 2347 Cases
In children who are still growing, outcomes tend to be even better. One study of skeletally immature patients who underwent microfracture for talar osteochondral lesions reported a 100% return to sports rate, with clinical scores improving significantly from before surgery to the final follow-up.27PubMed. Return to Sports Activity After Microfracture for Osteochondral Lesion of the Talus in Skeletally Immature Children
Where Treatment Is Heading
The big unsolved problem in osteochondral repair is rebuilding both layers of the unit (cartilage and bone) simultaneously, in a way that recreates the natural gradients the original tissue had. Current surgical options each compromise somewhere: microfracture gives you the wrong type of cartilage, autograft runs into supply limits, and allografts depend on tissue bank availability and can have variable cell viability.
Three-dimensional bioprinting is the technology generating the most excitement as a potential long-term solution. Researchers are developing multi-layered scaffolds that deposit different cell types, biomaterials, and signaling molecules in precisely arranged zones meant to mimic the osteochondral unit’s natural architecture.28PubMed Central. 3D bioprinted scaffolds for osteochondral regeneration: advancements and applications One recent study fabricated a two-layer (biphasic) living scaffold with a cartilage layer containing chondrocytes and stem cells, and a bone layer containing stem cells within a material that slowly released bioactive ions to promote bone formation. In animal models, the scaffold demonstrated simultaneous regeneration of both cartilage and bone.29Interdisciplinary Materials. Three‐dimensional bioprinting biphasic multicellular living scaffold facilitates osteochondral defect regeneration These approaches remain experimental and are years from routine clinical use, but they represent a fundamentally different strategy from current methods: instead of transplanting tissue that already exists, the goal is to print tissue that never existed before, customized to the exact shape and depth of a patient’s defect.
Choosing Between Procedures
One of the most confusing parts of navigating an osteochondral lesion diagnosis is figuring out which treatment is right for you, especially since there is no single universally agreed-upon algorithm. A few principles can help orient the decision:
- Lesion size matters most. Small defects (under roughly 1.5 cm²) are often well served by microfracture as a first attempt. Medium defects may be best addressed with autograft transfer. Large defects (over 3 cm²) or those with deep bony involvement usually require allograft or cell-based therapies like MACI.
- First surgery vs. revision. If a prior procedure has failed, allograft transplantation is often the go-to salvage option. Repeating the same technique rarely improves on a first failure.
- Activity goals. A competitive athlete with a medium-sized lesion might prefer autograft transfer for its superior return-to-sport profile. An older recreational walker with the same lesion might do perfectly well with microfracture, which involves a simpler procedure and shorter initial recovery.
- Age and healing capacity. Children and adolescents with open growth plates heal cartilage and bone more effectively, so conservative care or simpler surgical techniques are tried first. Adults lose that regenerative advantage and may need more complex procedures earlier in the treatment sequence.
- Joint location. The ankle talus is small, has thin cartilage, and has limited non-weight-bearing donor areas, which can make autograft harvest more challenging compared with the knee. This anatomic reality sometimes pushes ankle cases toward allograft or cell-based options sooner.
These are guidelines, not rules. Surgeons weigh imaging findings, symptom severity, prior treatments, and individual patient anatomy before recommending a specific approach. If you are facing this decision, getting a second opinion from a surgeon who specializes in cartilage restoration is often worthwhile, since the field is evolving quickly and experience varies widely.